Elanco Animal Health

ELAN · NYSE

$22.70−$0.79 (−3.36%)TodayMarket closed · Oct 20, 7:47 PM ET

Prev close $23.49

About ELAN

Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. The company is headquartered in Indianapolis, Indiana and currently employs 9,400 full-time employees. The company went IPO on 2018-09-20. The firm is engaged in delivering products and services to prevent and treat disease in farm animals and pets. The company serves animals across species, including dogs, cats, cattle, poultry, swine and sheep. Its pet health products help pets live longer, healthier and more active lives. Its pet health portfolio is focused on parasiticides, dermatology, vaccines and pain/other therapeutics. The company includes parasiticide portfolios in the pet health market based on indications, species and formulations, with products that protect pets from fleas, ticks and internal parasites. The company offers Advantage, K-9 Advantix, Advocate, and AdTab, which are over-the-counter treatments for the prevention and elimination of fleas and ticks. Its farm animal products help producers improve animal health and wellbeing. The company offers a farm animal portfolio of products for cattle including beef and dairy, poultry, swine and sheep.

Employees: 9,400
Headquarters: Indianapolis, Indiana
Listed: Sep 20, 2018
Sector: Health Care
Industry: Pharmaceuticals
Website: elanco.com

Leadership

Elanco Animal Health executives
Name	Title	Since	Age
Lawrence Kurzius	—	—	67
Jeffrey Simmons	—	2018	57
Robert Vanhimbergen	—	—	49
Todd Young	—	—	53
Shiv O'Neill	—	—	51
David Kinard	—	—	58
Timothy Bettington	—	—	51
Ramiro Cabral	—	—	53
Ellen de Brabander	—	—	62
Grace Mcardle	—	—	46
Rajeev Modi	—	—	44
Jose Manuel Simas	—	—	57
James Meer	—	—	55
Kapila Anand	—	—	71
Art Garcia	—	—	63
Michael Harrington	—	—	62
Paul Herendeen	—	—	69
R. David Hoover	—	—	79
Deborah Kochevar	—	—	—
Stacey Ma	—	—	55
Kirk Mcdonald	—	—	58
Denise Scots-Knight	—	—	65
Tiffany Kanaga	—	2025	—

Revenue by product and region

Fiscal year ended Dec 31, 2025: $4.71B total revenue

By region

International$2.48B52.6%
United States$2.23B47.4%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Elanco Animal Health suppliers and customers
Company	Relationship	Country	Correlation
Acrux ACR.AX	Supplier and customer	AU	0.89
Eden Research EDEN.L	Supplier and customer	GB	0.88
Tarsus Pharmaceuticals TARS	Supplier and customer	US	0.83
Covetrus Inc CVET	Customer	US	0.81
Petco Health and Wellness Company A WOOF	Customer	US	0.64
RaQualia Pharma	Supplier and customer	JP	0.62
WooGene B&G	Customer	KR	0.59
Mastermind MMND	Supplier	US	0.54
Novozymes B	Supplier and customer	DK	0.32
Paul Mueller MUEL	Supplier	US	-0.51

Similar companies

Companies in the same industry as Elanco Animal Health

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.